Related Experiment Videos
Hematology. Individualized methotrexate dosing in primary CNS lymphoma
1Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. abreyl@mskcc.org
Nature Reviews. Clinical Oncology
|June 3, 2010
Summary
High-dose methotrexate is effective for primary CNS lymphoma, but optimal dosing is unclear. This study suggests that methotrexate dose is crucial for patient outcomes, potentially optimizing treatment via an area under the curve model.
Area of Science:
- Oncology
- Pharmacokinetics
- Clinical Trials
Background:
- High-dose methotrexate is the standard chemotherapy for primary CNS lymphoma.
- Optimal dosing strategies for methotrexate in this context remain undefined.
Purpose of the Study:
- To investigate the utility of an area under the curve (AUC) model for optimizing methotrexate dosing.
- To determine the relationship between methotrexate dose and patient outcomes in primary CNS lymphoma.
Main Methods:
- Analysis of clinical trial data from the International Extranodal Lymphoma Study Group.
- Exploration of an area under the curve (AUC) pharmacokinetic model to assess methotrexate dosing.
Main Results:
- Methotrexate dose was identified as a significant factor influencing patient outcomes.
- The area under the curve (AUC) model shows potential for optimizing methotrexate therapy.
Conclusions:
- Effective methotrexate dosing is a critical determinant of successful treatment for primary CNS lymphoma.
- Pharmacokinetic modeling, such as AUC, may provide a framework for personalized methotrexate dosing strategies.
Related Concept Videos
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...